Clinuvel Pharmaceuticals Limited (ASX: CUV) trades on the Australian Securities Exchange at a share price of approximately $10.32 AUD. The biopharmaceutical equity has maintained a 52-week trading range spanning from a low of $8.35 to a high of $14.00 AUD, backed by a market capitalization of roughly $520 million AUD. Live pricing fluctuates throughout the standard ASX trading sessions based on daily institutional order flow and company announcements.